Revance Therapeutics Statistics
Total Valuation
SEIC has a market cap or net worth of $10.90 billion. The enterprise value is $10.15 billion.
| Market Cap | 10.90B |
| Enterprise Value | 10.15B |
Important Dates
The last earnings date was Wednesday, July 23, 2025, after market close.
| Earnings Date | Jul 23, 2025 |
| Ex-Dividend Date | Jun 9, 2025 |
Share Statistics
SEIC has 123.63 million shares outstanding. The number of shares has decreased by -2.20% in one year.
| Current Share Class | 123.63M |
| Shares Outstanding | 123.63M |
| Shares Change (YoY) | -2.20% |
| Shares Change (QoQ) | -1.68% |
| Owned by Insiders (%) | 9.32% |
| Owned by Institutions (%) | 73.58% |
| Float | 111.97M |
Valuation Ratios
The trailing PE ratio is 16.59 and the forward PE ratio is 17.00. SEIC's PEG ratio is 1.42.
| PE Ratio | 16.59 |
| Forward PE | 17.00 |
| PS Ratio | 5.09 |
| Forward PS | 4.54 |
| PB Ratio | 4.67 |
| P/TBV Ratio | 5.83 |
| P/FCF Ratio | 17.75 |
| P/OCF Ratio | 17.08 |
| PEG Ratio | 1.42 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.95, with an EV/FCF ratio of 16.53.
| EV / Earnings | 14.73 |
| EV / Sales | 4.60 |
| EV / EBITDA | 15.95 |
| EV / EBIT | 17.18 |
| EV / FCF | 16.53 |
Financial Position
The company has a current ratio of 6.18, with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.18 |
| Quick Ratio | 5.92 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.05 |
| Interest Coverage | 1,051.97 |
Financial Efficiency
Return on equity (ROE) is 30.06% and return on invested capital (ROIC) is 15.90%.
| Return on Equity (ROE) | 30.06% |
| Return on Assets (ROA) | 14.33% |
| Return on Invested Capital (ROIC) | 15.90% |
| Return on Capital Employed (ROCE) | 24.85% |
| Revenue Per Employee | $432,627 |
| Profits Per Employee | $135,204 |
| Employee Count | 5,098 |
| Asset Turnover | 0.86 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SEIC has paid $192.75 million in taxes.
| Income Tax | 192.75M |
| Effective Tax Rate | 21.85% |
Stock Price Statistics
The stock price has increased by +39.78% in the last 52 weeks. The beta is 0.94, so SEIC's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | +39.78% |
| 50-Day Moving Average | 88.11 |
| 200-Day Moving Average | 81.77 |
| Relative Strength Index (RSI) | 46.00 |
| Average Volume (20 Days) | 971,924 |
Short Selling Information
The latest short interest is 1.82 million, so 1.47% of the outstanding shares have been sold short.
| Short Interest | 1.82M |
| Short Previous Month | 1.90M |
| Short % of Shares Out | 1.47% |
| Short % of Float | 1.63% |
| Short Ratio (days to cover) | 1.95 |
Income Statement
In the last 12 months, SEIC had revenue of $2.21 billion and earned $689.27 million in profits. Earnings per share was $5.32.
| Revenue | 2.21B |
| Gross Profit | 1.74B |
| Operating Income | 591.21M |
| Pretax Income | 652.63M |
| Net Income | 689.27M |
| EBITDA | 636.76M |
| EBIT | 591.21M |
| Earnings Per Share (EPS) | $5.32 |
Balance Sheet
The company has $778.03 million in cash and $29.05 million in debt, giving a net cash position of $748.99 million or $6.06 per share.
| Cash & Cash Equivalents | 778.03M |
| Total Debt | 29.05M |
| Net Cash | 748.99M |
| Net Cash Per Share | $6.06 |
| Equity (Book Value) | 2.34B |
| Book Value Per Share | 18.90 |
| Working Capital | 1.28B |
Cash Flow
In the last 12 months, operating cash flow was $638.32 million and capital expenditures -$23.87 million, giving a free cash flow of $614.45 million.
| Operating Cash Flow | 638.32M |
| Capital Expenditures | -23.87M |
| Free Cash Flow | 614.45M |
| FCF Per Share | $4.97 |
Margins
Gross margin is 78.87%, with operating and profit margins of 26.81% and 31.25%.
| Gross Margin | 78.87% |
| Operating Margin | 26.81% |
| Pretax Margin | 39.99% |
| Profit Margin | 31.25% |
| EBITDA Margin | 28.87% |
| EBIT Margin | 26.81% |
| FCF Margin | 27.86% |
Dividends & Yields
This stock pays an annual dividend of $0.98, which amounts to a dividend yield of 1.11%.
| Dividend Per Share | $0.98 |
| Dividend Yield | 1.11% |
| Dividend Growth (YoY) | 6.52% |
| Years of Dividend Growth | 34 |
| Payout Ratio | 18.44% |
| Buyback Yield | 2.20% |
| Shareholder Yield | 3.31% |
| Earnings Yield | 6.32% |
| FCF Yield | 5.64% |
Analyst Forecast
The average price target for SEIC is $98.86, which is 12.09% higher than the current price. The consensus rating is "Buy".
| Price Target | $98.86 |
| Price Target Difference | 12.09% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 5.13% |
| EPS Growth Forecast (5Y) | 10.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 22, 2007. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 22, 2007 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
SEIC has an Altman Z-Score of 22.94 and a Piotroski F-Score of 5.
| Altman Z-Score | 22.94 |
| Piotroski F-Score | 5 |